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Abstract 
The process by which small proteins fold to their native conformations has been intensively 
studied over the last few decades. In this field, the particular chemistry of disulfide bond 
formation has facilitated the characterization of the oxidative folding of numerous small, 
disulfide-rich proteins with results that illustrate a high diversity of folding mechanisms, 
differing in the heterogeneity and disulfide pairing nativeness of their intermediates. In this 
review, we combine information on the folding of different protein models together with the 
recent structural determinations of major intermediates to provide new molecular clues in 
oxidative folding. Also, we turn to analyze the role of disulfide bonds in misfolding and protein 
aggregation and their implications in amyloidosis and conformational diseases.  
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Introduction 
In the absence of the cellular folding machinery, small proteins spontaneously fold to their 
native states under suitable conditions, implying that most of the information needed to specify 
a protein 3-D structure is contained within the amino acid sequence. To understand protein 
folding, over the past 30 years much experimental work has been focused on the identification 
and characterization of partially folded intermediates that occur along the folding reaction [1, 
2]. However, this process is usually very fast therefore the commonly used spectroscopic 
techniques (e.g., fluorescence and circular dichroism) provide limited information about the 
nature of intermediates that accumulate transiently. The use of small, disulfide-rich proteins, 
displaying folding intermediates that can be chemically trapped in a time-course manner, 
purified and structurally characterized, has proved to be very valuable for folding studies [3-5]. 
A large number of protein models comprising divergent and physiologically relevant functions, 
i.e., protease inhibitors, proteases, nucleases, growth factors and venom toxins, have been 
analyzed in detail to date and show an unexpected scenario of folding diversity.  
Intramolecular disulfide bonds (S-S) are important not only for the folding of secreted proteins, 
but also for their stability and function. In the last several years, there have been significant 
advances in the understanding of disulfide bond formation and rearrangement in the cell, for 
instance, concerning the role of protein disulfide isomerases (PDI) and their relatives (Dsb 
proteins) that catalyze both the formation and isomerization of disulfide bonds in the 
eukaryotic endoplasmic reticulum and prokaryotic periplasm, respectively (for reviews, see [6, 
7]). Because of the complex environment of the cell, however, more basic research is necessary 
to fully understand the concomitant relationship between protein folding and disulfide bond 
formation. Failure of these processes is likely to cause protein degradation by proteases or 
misfolding and subsequent aggregation (e.g., prion disorders) [8, 9].   
In this review, the folding behavior of the most-studied, small disulfide-rich proteins in the 
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literature is described. The determinants that account for the underlying diversity of folding 
landscapes and patterns of disulfide bond formation are addressed. Also, recent developments 
in the field, such as the structural determination of disulfide intermediates and studies of 
protein aggregation that may have important implications in protein folding and biomedicine 
are herein discussed. 
 
Disulfide bonds and oxidative folding  
The covalent link of cysteine residues by disulfide bonds is thought to serve distinct functions. 
First, they significantly influence the thermodynamics of protein folding: disulfide bonds 
stabilize the native conformation of a protein by lowering the entropy of the unfolded state, 
making it less favorable, as compared with the folded form. Second, they maintain protein 
integrity: oxidants and proteolytic enzymes in the extracellular environment can inactivate 
proteins. By stabilizing their structure, disulfide bonds protect proteins from damage, thus 
increasing their half-life [10]. Finally, although the disulfide bonds present in mature proteins 
have been considered chemically inert, now in some cases they appear to be cleaved or 
rearranged with significant consequences for their function (see review [11]).  
The native set of disulfide bonds is the end-result of an often-complicated process involving 
covalent reactions such as oxidation (S-S formation), reduction (S-S breaking) and 
isomerization/reshuffling (S-S rearrangement) [12]. The term “oxidative folding” describes the 
composite process by which a reduced, unfolded protein gains both its native disulfide bonds 
(disulfide bond generation) and its native structure (conformational folding) (for experimental 
details of the oxidative folding technique, see Box 1). The course of oxidative folding is 
affected by three structural factors that have been identified from different in vitro folding 
studies, namely, the proximity, reactivity and accessibility of thiol groups and disulfide bonds 
[13]. The proximity of two reactive groups, defined as their effective intramolecular 
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concentration, is determined by the propensity of the protein backbone chain to juxtapose two 
groups; in unfolded species, this proximity is largely determined by loop entropy and enthalpic 
interactions. The reactivity of the groups relies on the disulfide reactions that occur through a 
thiol-disulfide exchange in which only the thiolate group is reactive to perform the 
nucleophilic attack; therefore, changes in the local electrostatic environment may affect this 
parameter. Nevertheless, the most critical factor seems to be the accessibility of the thiol 
groups and disulfide bonds. Because thiol-disulfide exchange reactions occur only when a thiol 
and a disulfide bond come into contact, their burial prevents contact, hence blocking the 
reaction. 
Accordingly, the formation of a stable tertiary structure is a key event in the oxidative folding 
of proteins because it protects native disulfide bonds from reduction and reshuffling by making 
them inaccessible to protein thiols and redox agents [14]. The burial of both thiol groups and 
disulfide bonds in a disulfide intermediate may hinder any further progress in the folding 
reaction. In this regard, dead-end intermediates tend to be “disulfide-insecure” in that their 
structural fluctuations expose their disulfide bonds in concert with their thiol groups, leading to 
reshuffling rather than oxidation. These intermediates are normally long-lived “metastable” 
species that constitute rate-limiting steps in oxidative folding. In contrast, productive 
intermediates (leading to the native state) tend to be “disulfide-secure”, meaning that their 
structural fluctuations preferentially expose their thiol groups while keeping their disulfide 
bonds buried. This distinction helps to understand the oxidative folding of many disulfide-rich 
proteins included in following sections. 
 
Oxidative folding of BPTI and hirudin: two opposed models 
Extensive studies on small, disulfide-rich proteins have shown divergent mechanisms of 
folding that are illustrated by: (a) the extent of heterogeneity of folding intermediates, (b) the 
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predominance of intermediates containing native disulfide bonds, and (c) the accumulation of 
scrambled isomers (fully oxidized species that contain at least two non-native disulfide bonds) 
as intermediates. On the basis of these points, bovine pancreatic trypsin inhibitor (BPTI) and 
hirudin represent two notable models with very different folding characteristics. The original 
studies on BPTI (58 residues; containing three disulfide bonds), conducted by Creighton et al. 
and later revised by Weissman and Kim, resulted in one of the most extensively studied models 
of oxidative folding [15-18]. They showed that the folding of BPTI is characterized by the 
predominance of a limited number of 1- and 2-disulfide intermediates (five of 75 possible) that 
adopt native disulfide pairings and native-like substructures (Figure 1). These intermediates 
seem to funnel protein conformations toward the native state and prevent the accumulation of 
3-disulfide scrambled isomers. The rate-limiting step of the process is then the conversion of 
2-disulfide intermediates into the intermediate processor that rapidly forms the third and final 
native disulfide. Venom neurotoxins like α62 (structured in a “three-finger fold”; four 
disulfide bonds), the squash trypsin inhibitor EETI-II and the cyclotide protein kalata B1 (28 
and 29 residues; three disulfide bonds) share similar folding with that of BPTI [19-21]. 
Likewise, the folding of the 3-disulfide insulin-like growth factor (IGF-1; 70 residues), which 
folds into two isomers (native and swap) with different disulfide linkages but similar 
thermodynamic stability, bears resemblance to that of BPTI [22]. Interestingly, this kind of 
folding is in line with the “framework model”, which stresses the importance of local 
interactions in reducing conformational search and in guiding efficient protein folding through 
the hierarchic condensation of native-like elements.   
The oxidative folding of hirudin (core domain, 49 residues; three disulfide bonds) differs from 
that of BPTI in the three folding features mentioned above: (a) folding intermediates are far 
more heterogeneous (at least 30 fractions of 1- and 2-disulfide intermediates have been 
identified), (b) predominant intermediates adopting native disulfides are absent, and (c) 
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3-disulfide scrambled isomers strongly accumulate [23, 24]. Taken together, the folding of 
hirudin can be dissected into two stages: an initial stage of non-specific disulfide bond 
formation (packing) leading to the formation of scrambled species, followed by a final stage of 
disulfide reshuffling (consolidation) of a heterogeneous scrambled population leading to the 
native structure (Figure 1). It is worth mentioning that the oxidative folding of many other 
small 3-disulfide proteins is similar to that of hirudin; among them, tick anticoagulant peptide 
(TAP; 60 residues), various venom neurotoxins and proteins stabilized by “cystine-knot” 
disulfide bonds such as potato carboxypeptidase inhibitor (PCI; 39 residues) and Amaranthus 
α-amylase inhibitor (AAI; 32 residues) [25-30]. The hirudin folding is consistent with the 
“collapse model” that depicts protein folding as an initial stage of rapid hydrophobic collapse, 
followed by slower annealing in which specific interactions refine the structure rather than 
dominate the folding code. Importantly, these studies have contradicted conventional wisdom, 
which considered scrambled isomers as abortive “off-pathway” folding intermediates. The 
presence of productive, “on-pathway” scrambled isomers seems to be frequent in the oxidative 
folding of small, disulfide-rich proteins. 
 
Mixing folding mechanisms: the cases of EGF and LCI 
The oxidative folding of epidermal growth factor (EGF) and leech carboxypeptidase inhibitor 
(LCI) serve to magnify the extent of diversity of disulfide folding landscapes because it 
displays both similarity and dissimilarity to the folding of BPTI and hirudin. EGF (53 residues; 
three disulfide bonds) folds through several 1-disulfide intermediates that rapidly form a single 
2-disulfide intermediate with native disulfide bonds [31, 32]. This species acts as a major 
kinetic trap of the process since it can represent more than 85% of the protein. The pathway of 
this intermediate to the native structure proceeds through 3-disulfide scrambled isomers 
(Figure 2). Similar to EGF, the recently determined oxidative folding of LCI (67 residues; four 
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disulfide bonds) undergoes a sequential flow through 1- and 2-disulfide intermediates that 
rapidly accumulate as two predominant 3-disulfide intermediates with native disulfide pairings 
[33, 34]. These two species act as major kinetic traps of the process, which need structural 
rearrangements through the formation of 4-disulfide scrambled isomers to attain the native 
structure. Thus, EGF and LCI display an analogue folding that resembles that of BPTI by the 
presence of few predominant native-like intermediates. But, at the same time, it is also similar 
to that of hirudin due to the initial formation of heterogeneous populations of intermediates and 
the final rate-limiting step of conversion of scrambled isomers into the native protein.  
 
Diversity in the oxidative folding of α-lactalbumin 
Folding diversity of small, disulfide-rich proteins seems to depend crucially on the presence (or 
absence) of localized, stable domain structures. An outstanding example to illustrate this 
hypothesis is the mechanism of oxidative folding of α-lactalbumin (αLA) elucidated in the 
absence or presence of calcium (Figure 3) [35, 36]. αLA (122 residues; four disulfide bonds) 
comprises an α-helical domain and a β-sheet domain that is considerably stabilized upon 
binding to calcium [37]. In the absence of calcium, the oxidative folding of αLA resembles that 
of hirudin, proceeding through the formation of heterogeneous populations of 1-, 2- and 
3-disulfide intermediates and with the final accumulation of 4-disulfide scrambled isomers. 
Binding of calcium changes the folding process of αLA significantly because it 
thermodynamically stabilizes the β-sheet domain. Consequently, the complexity of folding 
intermediates diminishes drastically and the process now involves the accumulation of two 
predominant intermediates that adopt native disulfide-bond pairings and native-like structures 
of the β-sheet domain. Thus, in the presence of calcium, the folding of αLA bears close 
resemblance to what is observed in BPTI folding. 
To provide more insight into the role played by stable-structure elements in oxidative folding, 
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the reductive unfolding process of several model proteins has been examined (for details of this 
technique, see Box 1) [38, 39]. A striking correlation is observed between the mechanisms of 
oxidative folding and reductive unfolding. Those proteins with their native disulfide bonds 
reduced collectively in an “all-or-none” mechanism, without significant accumulation of 
partially reduced species, display both a high degree of heterogeneity of folding intermediates 
and the formation of scrambled isomers along their oxidative folding (e.g., hirudin, TAP, PCI, 
AAI and αLA). For these proteins, it is only at the final stage of folding (consolidation) where 
the attainment of the native disulfide bonds is guided by specific non-covalent interactions, 
which results in the cooperative and concerted stabilization of disulfide bonds [40]. In contrast, 
a sequential reduction of the native disulfide bonds is associated with the presence of 
predominant intermediates with native-like structures during folding (e.g., BPTI, EETI-II and 
calcium-bound αLA).  
 
“Locking in” intermediates: the oxidative folding of RNase A 
The oxidative folding of ribonuclease A (RNase A) has been extensively studied over the past 
several years by Scheraga et al. [13, 41-43]. In RNase A (124 residues), its four disulfide bonds 
are paired within very different secondary-structure elements: while 40-95 and 65-72 S-S 
occur in relatively flexible loop segments, 26-84 and 58-110 S-S join an α-helix to a β-sheet, 
stabilizing the surrounding local hydrophobic core. In the early stages of RNase A folding, 1-, 
2-, 3- and 4-disulfide (scrambled) intermediates are formed by successive oxidations, until a 
pre-equilibrium is established among them (Figure 2). Interestingly, the distribution of 
disulfide intermediates within the 1S and 2S ensembles (collection of 1- and 2-disulfide 
species, respectively) is enthalpically biased toward native disulfide bonds, as concluded from 
the recent experiments performed with the compound trans-[Pt(en)2Cl2]2+, which oxidizes 
thiol groups faster than the rate at which thiol-disulfide exchange reactions can take place [44]. 
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The final and rate-limiting stage in the attainment of native RNase A is the formation of two 
intermediates, des[40-95] and des[65-72] (i.e., intermediates lacking the 40-95 and 65-72 S-S, 
respectively), with native disulfide-bond pairings and native-like structures. These species are 
formed mainly by the reshuffling of 3-disulfide intermediates, although a small fraction (up to 
5%) may be formed by oxidation from the 2S ensemble. Upon formation of a stable tertiary 
structure, their three native disulfide bonds become protected from reduction and reshuffling 
(“locked in”), causing these “des species” to accumulate at high levels. However, their thiol 
groups remain solvent-accessible and, hence, these disulfide-secure intermediates oxidize 
relatively rapidly to the native protein. The protective structure of these two species is a critical 
factor in promoting the oxidative folding of RNase A [14]. The other two des species of the 3S 
ensemble, des[26-84] and des[58-110], are metastable dead-end intermediates that reshuffle 
preferentially to the 3S ensemble rather than oxidize to the native protein. Presumably, these 
two disulfide-insecure intermediates bury both their thiol groups and disulfide bonds in 
hydrophobic cores of a native-like structure, thus inhibiting oxidation as well as reduction and 
reshuffling. The specific reasons behind the accumulation of metastable intermediates have 
been determined recently from several structural characterizations of intermediates (see Box 
2). 
The effects of “locking in” native disulfide bonds are also illustrated by the BPTI, LCI and 
lysozyme models. Despite its small size, BPTI has two hydrophobic cores that may fold 
semi-independently. Specifically, the formation of the 5-55 S-S induces global folding, while 
the formation of the 30-51 S-S causes only one core to fold. In intermediates containing either 
5-55 or 30-51 S-S, the other native S-S (14-38) forms quickly, producing the des[30-51] and 
des[5-55] species, respectively [45]. However, these des species appear to be 
disulfide-insecure intermediates, preferentially reshuffling rather than oxidizing. Therefore, 
the productive precursor of native BPTI is the disulfide-secure des[14-38] intermediate and the 
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rate-limiting step of the folding process is either a reshuffling to form des[14-38] or the escape 
from the dead-end metastable des[30-51] and des[5-55] species. In the oxidative folding of LCI, 
the des[19-43] and des[22-58] species, lacking the native disulfide bond that connects the 
α-helix to the β-sheet and stabilizes the β-sheet core, respectively, also seem to behave as 
metastable, disulfide-insecure intermediates with a high content of a native-like structure [46]. 
Lysozyme (129 residues; four disulfide bonds) is a more complex protein that comprises two 
folding domains, called the α- and β-domains. A heterogeneous ensemble of relatively 
unstructured intermediates (containing 1S and 2S) is rapidly formed from the reduced protein 
after initiation of folding [47-49]. In these early stages, and similarly to BPTI and RNase A 
folding, the dominance of native-like interactions results in some conformational ordering and 
bias toward the attainment of native disulfide bonds. Three structured des species are 
subsequently formed: des[6-127], des[64-80] and des[76-94]. The majority of molecules 
slowly form the native 4-disulfide structure via rearrangement from des[76-94], which appears 
to be a native-like, metastable disulfide-insecure intermediate (the 76-94 S-S links the two 
domains of lysozyme). The rest of the population (~ 30%) folds more quickly via the other two 
des species.  
 
Disulfide bonds and aggregation  
The presence of insoluble protein deposits in human tissues correlates with the development of 
many debilitating disorders including amyloidosis and several neurodegenerative diseases. In a 
number of proteins related to conformational diseases, improper disulfide bond formation may 
result in structural rearrangements of the polypeptide chain leading to increased aggregation. 
One of the first pieces of evidence of that came from pioneering studies by Dobson et al. on 
lysozyme, a protein that later was shown to form amyloid fibrils in individuals suffering from 
non-neuropathic systemic amyloidosis [50, 51]. Lysozyme aggregation takes place during the 
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early stages of the folding reaction and is strongly prevented by the presence of PDI, which 
facilitates the attainment of the native state [52]. This reflects the importance of folding 
catalysts in physiological folding and suggests an important role avoiding aggregation of 
partially folded molecules in the intracellular environment. 
The reduction of disulfide bonds has been shown to critically affect amyloid formation. For 
Bence Jones proteins, which are the major component of the amyloid fibrils in patients with 
systemic AL-amyloidosis, the reduction of native disulfide bonds leads to non-native protein 
association and formation of amyloid-like aggregates [53]. In the case of Amylin, found in islet 
amyloid deposits of Type II diabetes, disulfide bonds play a central role in the assembly 
mechanism and kinetics of fibril formation [54]. The disulfide linkage of β2-microglobulin, 
whose aggregation into amyloid deposits is common in patients with long-term hemodialysis, 
seems to protect against deposition by reducing conformational fluctuations and maintaining 
the global native-like topology [55]. Accordingly, disulfide bond reduction both destabilizes 
the native state and enhances the conformational flexibility of the polypeptide, resulting in 
increased formation of oligomeric structures. In addition, there is the special case of the prion 
protein, which causes transmissible spongiform encephalopathies. The oxidative folding of 
reduced, monomeric non-infective form PrPC has been shown to result in the formation of an 
oligomeric, protease-resistant species with a high content of β-sheet structure joined by 
intermolecular disulfide bonding [56, 57]. More importantly, it has been demonstrated that the 
aberrant "scrapie" isoform (PrPSc) is able to convert native PrPPC into oligomers, thus proposing 
a mechanism for prion self-propagation (Figure 4). 
Finally, the formation of new non-native intramolecular disulfide bonds may also result in 
aggregation. This is the case of superoxide dismutase (SOD), a protein that has been implicated 
in the familial form of the neurodegenerative disease amyotrophic lateral sclerosis [58]. SOD1 
has four cysteines, two linked and two free in the native structure. Formation of a new disulfide 
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bond between the originally free cysteines serves to trap SOD1 in aggregation-prone 
conformations and produce accelerated protein deposition. 
 
Concluding remarks and future perspectives 
In the last few years, the results obtained from many studies on small, disulfide-rich proteins 
have substantially clarified the understanding of oxidative folding mechanisms. The folding of 
proteins like hirudin, PCI or AAI has shown the interdependence between conformational 
folding and assembly of native disulfide bonds. Because of the large heterogeneity of species at 
the start of the folding process, disulfide bonds are necessary to restrict the search in 
conformational space by cross-linking the protein in its unfolded state. In the cell this is most 
likely achieved with the help of folding catalysts, for instance, PDI, which may reduce and 
reshuffle non-native disulfide bonds at the early stages of folding to avoid misfolding.  
Other works have highlighted the critical role of accessibility of both disulfide bonds and thiol 
groups, as observed in the oxidative folding of RNase A, BPTI or LCI. For these proteins, the 
critical step seems to be the formation of a stable tertiary structure that sequesters the native 
disulfide bonds (preventing subsequent rearrangements) but leaves the thiol groups of 
intermediates relatively exposed (or exposable) for subsequent oxidation. The “locking in” of 
native disulfide bonds by conformational folding could also assist the oxidative folding of 
larger disulfide-rich proteins. For such proteins, the absence of either structured intermediates 
or a strong native bias would hinder the folding reaction significantly. However, the 
independent folding of (sub)domains could help in overcoming this entropic barrier by 
successively locking in disulfide bonds and protecting native pairings from further 
rearrangements. This approach could also operate in vivo, where oxidative folding can occur 
co-translationally. Future experiments in this direction for regenerating large, multi-domain 
proteins would be very challenging.  
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Also, the assistance of computational algorithms able to analyze folding free energy 
landscapes of disulfide-rich polypeptides would be of much interest. Unfortunately and despite 
the exciting new insights on the folding of disulfide-free proteins provided by theoretical 
approaches [59], the apparent complexity and diversity of their folding pathways have kept 
bioinformatics research away form disulfide-rich proteins. As reported here, it is coming clear 
that general rules govern the disulfide folding pathways, thus providing a unique opportunity 
for the future development of computational methods to predict and design the folding of this 
set of proteins. 
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Figure legends 
Figure 1. Schematic overview of opposite landscapes in oxidative folding. (A) For proteins 
like BPTI, a limited number of 1- and 2-disulfide intermediates, comprising native disulfide 
pairings and native-like structures, funnel protein conformations toward the native state. (B) 
Hirudin-like proteins fold through an initial stage of disulfide bond formation (packing) 
followed by the reshuffling of scrambled isomers (consolidation) to form the native protein. 
The heterogeneous ensembles of 1-, 2- and 3-disulfide intermediates are indicated by 1S, 2S 
and 3S, respectively.  
 
Figure 2. Comparative folding of small disulfide-rich proteins. R and N indicate the reduced 
and native forms, respectively. 1S, 2S, 3S, and 4S are ensembles of molecules with the 
corresponding number of disulfide bonds. The disulfide pairings of folding intermediates are 
shown between parentheses and the missing disulfides between square brackets. The native 
structure of each protein is depicted as a ribbon plot, including native disulfide pairings (in 
yellow). The calcium atom bound to αLa is represented by a red sphere. Interestingly, BPTI 
and TAP, both containing three disulfide bonds, have an almost identical size, structure and 
disulfide pairing but differ completely in their mechanism of oxidative folding. 
 
Figure 3. Oxidative folding of αLA in the absence or presence of calcium. Folding of αLA 
(0.5 mg/mL) was carried out in Tris-HCl buffer (pH 8.4) containing 0.2 mM 
2-mercaptoethanol, with or without 5 mM CaCl2. Folding intermediates were trapped by 
acidification (4% trifluoroacetic acid) in a time-course manner and further analyzed by 
RP-HPLC. N and R indicate the elution position of the native and fully reduced protein, 
respectively. IIIA and IIA stand for two predominant 3- and 2-disulfide intermediates, 
respectively, comprising native disulfide bond pairings. Adapted, with permission, from Ref. 
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[36]. 
 
Figure 4. Disulfide-dependent aggregation of the prion protein. (A) Model of oligomerization 
and conversion of prion protein PrP from its normal cellular form (PrPC) to an infectious 
"scrapie" isoform (PrPSc). A terminal thiolate of the disulfide-linked oligomer attacks the 
intramolecular disulfide bond of PrPC forming an intermolecular disulfide bond. This builds up 
the polymer while maintaining a reactive thiolate in terminal position ready to attack the next 
monomer. A conformational transition to a more rigid, β-enriched scrapie isoform would 
protect the intermolecular disulfide bonds, inhibiting the reaction of depolymerization. (B, C) 
Electron micrographs showing the oligomeric form of PrP[90-231] formed after reduction of 
the conserved disulfide bond. (B) Oligomers at completion of the process. (C) Oligomers at 
completion of the process in which the initial solution has been seeded with the oligomers from 
B (ratio of PrPSc seeds to PrPC is 1:10). Adapted, with permission, from Ref. [56]. 
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Box 1. Oxidative folding and reductive unfolding techniques 
In the technique of oxidative folding, pioneered by Creighton et al. [60], disulfide-containing 
proteins are initially fully reduced and denatured. After removal of both reagents, the reduced 
and denatured proteins are allowed to refold (at ~ pH 8.5) in the presence of selected buffers 
containing different redox agents. The folding intermediates are then trapped in a time-course 
manner and subsequently analyzed using several techniques. Thus, the disulfide-folding 
landscape is elucidated from the mechanism of formation of disulfide bonds, and characterized 
by the heterogeneity and structures of disulfide species that accumulate along the process of 
oxidative folding. The original studies of oxidative folding were based on the irreversible 
trapping of intermediates by alkylation (with iodoacetate) and further analysis by ion-exchange 
chromatography. Nevertheless, rearrangements of intermediates during the trapping procedure 
were observed for both BPTI and RNase A [18]. The most effective method seems to be the 
reversible quenching of the solution by acidification (usually with trifluoroacetic acid at pH ≤ 2) 
and analysis of the trapped intermediates by reversed-phase high performance liquid 
chromatography (RP-HPLC) [32]; see the example of αLA in Figure 3. This strategy permits 
not only the structural characterization of the intermediates, but also stop/go studies of them 
after readjusting the pH. In oxidative folding, the influence of redox agents on the folding 
process and the efficiency of recovery of the native protein can be achieved by using different 
redox agents, for instance, cystine and oxidized glutathione (GSSG), which promote disulfide 
formation, and cysteine, reduced glutathione (GSH) and 2-mercaptoethanol, which promote 
disulfide bond reshuffling. 
In the reductive unfolding technique [61], native disulfide-containing proteins are treated with 
different concentrations of reducing agent (e.g., dithiothreitol; DTT) in the absence of 
denaturant. To monitor the unfolding reaction (performed at ~ pH 8.5), aliquots of the sample 
are removed at various time intervals, quenched by acidification (or alternatively by alkylation) 
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and analyzed by RP-HPLC. The mode of reduction will have crucial implications in 
interpreting the stabilization of disulfide bonds in the native state by protein structure (see main 
text). 
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Box 2. Structures of intermediates: shedding light on protein folding 
Although some intermediates have been directly purified from the folding reaction (see below), 
most studies have taken advantage of the construction of analogues in which the free cysteine 
residues are replaced with alanine or serine residues. The first intermediate analogues to be 
analyzed were those of BPTI. NMR studies on analogues [5-55] and [30-51] showed a partially 
folded structure that was structurally similar to that of native BPTI [62, 63]. Additionally, an 
analogue of the des[5-55] species displayed a structure almost identical to native BPTI, despite 
some differences in the N- and C-terminal regions [64]. For RNase A, NMR analysis of the 
des[40-95] and des[65-72] intermediate analogues also revealed native-like structures [65, 66]. 
However, small structural differences spatially adjacent to the mutation sites accounted for 
lower stability compared to the native protein (Figure I). An analogue of the MFI scrambled 
isomer of AAI was recently characterized by NMR, providing clues on the role of structural 
constraints in directing the folding process: the compact fold brings the cysteine residues into 
close proximity, thus facilitating reshuffling to native disulfide bonds [67]. Also, scrambled 
isomers of the peptide α-conotoxin GI were synthesized and characterized with implications 
for its structure and stability [68]. 
“Real” intermediates of other small, disulfide-rich proteins (with reactive cysteines, unlike the 
analogues) have been trapped, isolated by RP-HPLC and further characterized by NMR. The 
highly native-like structure of the des[76-94] intermediate of lysozyme clearly depicted the 
reasons behind its accumulation during folding: its Cys94 thiol is not solvent-accessible and 
therefore direct oxidation to the fully native protein is restricted [69]. The recently determined 
structure of the major intermediate of LCI, des[22-58] (named III-A), correlates with the 
finding on lysozyme [70]; III-A displays a native-like structure and its two free cysteine 
residues are buried (confirmed by NMR amide-proton exchange experiments) (Figure I). 
Besides the accessibility of thiol groups, other factors like proximity may affect the formation 
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of disulfide bonds. Thus, for kalata B1, the recently determined structure of its major 
intermediate, des[1-15], revealed a native-like structure that maintains the two cysteine 
residues distant from each other, thereby preventing direct oxidation to the final disulfide bond 
[19]. The overall results presented here emphasize the necessity of high-resolution structure 
determinations of real intermediates to fully understand disulfide folding. 
 
Figure I. Ribbon structures of native RNase A and LCI together with their predominant 
folding intermediates des[40-95] and des[22-58]. 
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